AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionAsset Dedication, LLC
Latest Disclosed Ownership8,960 shares
Latest Disclosed Value $ 1,948,756
Asset Dedication, LLC reports 16.39% decrease in ownership of ABBV / AbbVie Inc.

On May 29, 2026 - Asset Dedication, LLC filed a 13F-HR form disclosing ownership of 8,960 shares of AbbVie Inc. (US:ABBV) valued at $1,948,710 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 10,716 shares of AbbVie Inc.. This represents a change in shares of -16.39% during the quarter. The current value of the position is $1,945,485 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-29 2026-03-31 13F ABBVIE COM 00287Y109 8,960 -1,756 -16.39 1,949 -20.42 0.1365
2026-01-26 2025-12-31 13F ABBVIE COM 00287Y109 10,716 -384 -3.46 2,449 -4.75 0.1607
2025-11-20 2025-09-30 13F ABBVIE COM 00287Y109 11,100 -680 -5.77 2,570 17.57 0.1727
2025-08-19 2025-06-30 13F ABBVIE COM 00287Y109 11,780 712 6.43 2,187 -5.74 0.1588
2025-05-01 2025-03-31 13F ABBVIE COM 00287Y109 11,068 -758 -6.41 2,319 10.38 0.1882
2025-01-23 2024-12-31 13F ABBVIE COM 00287Y109 11,826 -4,388 -27.06 2,101 -34.36 0.1654
2024-10-15 2024-09-30 13F ABBVIE COM 00287Y109 16,214 -4,162 -20.43 3,202 -8.39 0.2160
2024-08-06 2024-06-30 13F ABBVIE COM 00287Y109 20,376 -403 -1.94 3,495 116,366.67 0.2424
2024-04-16 2024-03-31 13F AbbVie Equities 00287Y109 20,779 8,713 72.21 4 200.00 0.2823
2024-02-08 2023-12-31 13F AbbVie Equities 00287Y109 12,066 -2,329 -16.18 2 -50.00 0.1516
2023-11-13 2023-09-30 13F AbbVie Equities 00287Y109 14,395 1,120 8.44 2 100.00 0.1828
2023-08-22 2023-06-30 13F AbbVie Equities 00287Y109 13,275 -641 -4.61 2 -50.00 0.1536
2023-04-24 2023-03-31 13F AbbVie Equities 00287Y109 13,916 514 3.84 2 0.00 0.2054
2023-01-19 2022-12-31 13F AbbVie Equities 00287Y109 13,402 1,210 9.92 2 -99.88 0.2201
2022-10-27 2022-09-30 13F AbbVie Equities 00287Y109 12,192 379 3.21 1,636 -9.61 0.1796
2022-07-19 2022-06-30 13F AbbVie Equities 00287Y109 11,813 50 0.43 1,810 -4.94 0.2689
2022-04-21 2022-03-31 13F AbbVie Equities 00287Y109 11,763 -2,195 -15.73 1,904 0.63 0.2121
2022-01-21 2021-12-31 13F AbbVie Equities 00287Y109 13,958 5,168 58.79 1,892 99.58 0.2279
2021-10-18 2021-09-30 13F AbbVie Equities 00287Y109 8,790 1,712 24.19 948 19.10 0.1249
2021-07-21 2021-06-30 13F AbbVie Equities 00287Y109 7,078 358 5.33 796 9.79 0.1186
2021-05-03 2021-03-31 13F AbbVie Equities 00287Y109 6,720 -438 -6.12 725 -5.60 0.1638
2021-01-28 2020-12-31 13F AbbVie Equities 00287Y109 7,158 -295 -3.96 768 17.61 0.1531
2020-10-20 2020-09-30 13F AbbVie Equities 00287Y109 7,453 544 7.87 653 -3.55 0.1441
2020-08-24 2020-06-30 13F AbbVie Equities 00287Y109 6,909 -614 -8.16 677 18.15 0.1844
2020-05-05 2020-03-31 13F AbbVie Equities 00287Y109 7,523 1,287 20.64 573 3.80 0.1705
2020-01-31 2019-12-31 13F AbbVie Equities 00287Y109 6,236 386 6.60 552 24.04 0.1560
2019-10-17 2019-09-30 13F AbbVie Equities 00287Y109 5,850 1,646 39.15 445 45.42 0.1480
2019-07-23 2019-06-30 13F AbbVie Equities 00287Y109 4,204 -208 -4.71 306 -13.56 0.0987
2019-04-19 2019-03-31 13F AbbVie Equities 00287Y109 4,412 -13 -0.29 354 -13.24 0.1232
2019-02-12 2018-12-31 13F AbbVie Equities 00287Y109 4,425 -2,364 -34.82 408 -36.35 0.1674
2018-10-26 2018-09-30 13F AbbVie Equities 00287Y109 6,789 -391 -5.45 641 -3.75 0.2409
2018-08-13 2018-06-30 13F AbbVie Equities 00287Y109 7,180 -150 -2.05 666 -3.62 0.2274
2018-04-19 2018-03-31 13F AbbVie Equities 00287Y109 7,330 751 11.42 691 8.99 0.3427
2018-01-17 2017-12-31 13F AbbVie Equities 00287Y109 6,579 2,472 60.19 634 73.70 0.2553
2017-10-18 2017-09-30 13F AbbVie Equities 00287Y109 4,107 -138 -3.25 365 18.89 0.1760
2017-07-17 2017-06-30 13F AbbVie Equities 00287Y109 4,245 -339 -7.40 307 3.02 0.1544
2017-04-20 2017-03-31 13F AbbVie Equities 00287Y109 4,584 -90 -1.93 298 1.36 0.1609
2017-01-17 2016-12-31 13F AbbVie Equities 00287Y109 4,674 402 9.41 294 9.29 0.1705
2016-11-18 2016-09-30 13F/A-2 AbbVie Equities 00287Y109 4,272 100 2.40 269 3.86 0.1699
2016-10-19 2016-09-30 13F Abbvie Inc Com Usd0.01 Equities 00287Y109 5,006 284
2016-11-18 2016-06-30 13F/A-1 AbbVie Equities 00287Y109 4,172 -834 -16.66 259 -9.44 0.1800
2016-07-14 2016-06-30 13F Abbvie Inc Com Usd0.01 Equities 00287Y109 5,006 284
2016-04-27 2016-03-31 13F Abbvie Equities 00287Y109 5,006 -389 -7.21 286 -10.62 0.2103
2016-02-16 2015-12-31 13F Abbvie Inc Com Usd0.01 EQUITIES 00287Y109 5,395 5,395 320 0.2100
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.